Atb Cap Markets Forecasts Organigram FY2027 Earnings

Organigram Holdings Inc. (TSE:OGI - Free Report) - Equities researchers at Atb Cap Markets issued their FY2027 earnings per share estimates for shares of Organigram in a report released on Tuesday, February 11th. Atb Cap Markets analyst F. Gomes forecasts that the company will post earnings of $0.08 per share for the year. The consensus estimate for Organigram's current full-year earnings is $0.16 per share. Atb Cap Markets also issued estimates for Organigram's FY2028 earnings at $0.20 EPS.

A number of other brokerages have also weighed in on OGI. ATB Capital decreased their price objective on shares of Organigram from C$5.25 to C$3.50 in a report on Tuesday, December 17th. Canaccord Genuity Group decreased their price target on Organigram from C$3.60 to C$3.15 and set a "speculative buy" rating for the company in a research note on Monday, December 9th.

Organigram Stock Down 5.7 %

Organigram stock traded down C$0.11 during trading hours on Thursday, hitting C$1.81. The stock had a trading volume of 569,842 shares, compared to its average volume of 297,886. The company has a quick ratio of 2.62, a current ratio of 3.36 and a debt-to-equity ratio of 3.07. The stock has a market capitalization of C$223.61 million, a P/E ratio of -3.83, a price-to-earnings-growth ratio of 0.42 and a beta of 1.13. Organigram has a 12-month low of C$1.80 and a 12-month high of C$3.95. The stock's 50-day moving average price is C$2.23 and its 200-day moving average price is C$2.31.

About Organigram

Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.